Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia

Evaluations of the ‘real-world’ efficacy and safety of tyrosine kinase inhibitors in patients with chronic myeloid leukemia are scarce. A nationwide, population-based, chronic myeloid leukemia registry was analyzed to evaluate (deep) response rates to first and subsequent treatment lines and eligibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Geelen, Inge G.P., Thielen, Noortje, Janssen, Jeroen J.W.M., Hoogendoorn, Mels, Roosma, Tanja J.A., Willemsen, Sten P., Visser, Otto, Cornelissen, Jan J., Westerweel, Peter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664388/
https://www.ncbi.nlm.nih.gov/pubmed/28860339
http://dx.doi.org/10.3324/haematol.2017.174953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664388/
https://www.ncbi.nlm.nih.gov/pubmed/28860339
http://dx.doi.org/10.3324/haematol.2017.174953

Ejemplares similares